MAPT and Alzheimer disease: In addition, the current study did not incorporate serum Aβ and p-tau, which are well-established biomarkers for the evaluation of AD patients, partly because the diagnosis of VD primarily relies on clinical and imaging findings, as there is a lack of universally recognized biomarkers for VD.